Agreed, T&P you are grasping at straws trying to read between the lines.
The recent “come to Jesus” moment was driven by unprecedented investor dissatisfaction, I would bet that many investors were expressing their dissatisfaction more broadly than IMU management would like, I bet that this pressure instigated by complaints to regulatory bodies by pissed off investors and this was their attempt to quell the angry beast. I urge all investors to keep the foot on their throat - after all the rhetoric can anyone tell me when I will see Vaxinia or Oncarlytics data?
IMU Price at posting:
2.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)